Yesterday, March 15, 2016, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $710.84 to $145,264,601.52.

Highlighted Stocks Traded by Insiders:

Energy Fuels (UUUU) - FREE Research Report

Bovaird J. Birks, who is Director at Energy Fuels, bought 3,125 shares at $2.40 on March 15, 2016. Following this transaction, the Director owned 49,432 shares meaning that the stake was boosted by 6.75% with the 3,125-share transaction.

Antony Stephen P., who is President & CEO at Energy Fuels, bought 10,000 shares at $2.40 on March 15, 2016. Following this transaction, the President & CEO owned 226,804 shares meaning that the stake was boosted by 4.61% with the 10,000-share transaction.

The shares most recently traded at $2.34, down $0.06, or 2.56% since the insider transaction.

The average volume for Energy Fuels has been 261,800 shares per day over the past 30 days. Energy Fuels has a market cap of $108.1 million and is part of the basic materials sector and metals & mining industry. Shares are down 22.03% year-to-date as of the close of trading on Tuesday.

Energy Fuels Inc., together with its subsidiaries, engages in the acquisition, exploration, and development of uranium and vanadium properties in the United States. Its principal properties are located in Colorado, Utah, Arizona, Wyoming, and New Mexico. Currently, there are 5 analysts who rate Energy Fuels a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UUUU - FREE

TheStreet Quant Ratings rates Energy Fuels as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, unimpressive growth in net income and generally disappointing historical performance in the stock itself. Get the full Energy Fuels Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Zayo Group Holdings (ZAYO) - FREE Research Report

Connor Richard W., who is Director at Zayo Group Holdings, sold 5,000 shares at $25.00 on March 15, 2016. Following this transaction, the Director owned 154,268 shares meaning that the stake was reduced by 3.14% with the 5,000-share transaction.

The shares most recently traded at $24.19, down $0.81, or 3.35% since the insider transaction. Historical insider transactions for Zayo Group Holdings go as follows:

  • 4-Week # shares sold: 50,000
  • 12-Week # shares sold: 100,000
  • 24-Week # shares sold: 1.0 million

The average volume for Zayo Group Holdings has been 1.6 million shares per day over the past 30 days. Zayo Group Holdings has a market cap of $6.0 billion and is part of the technology sector and computer hardware industry. Shares are down 7.6% year-to-date as of the close of trading on Tuesday.

Zayo Group Holdings, Inc., through its subsidiaries, provides bandwidth infrastructure solutions for the communications industry in the United States and Europe. The company operates in three segments: Physical Infrastructure, Cloud and Connectivity, and Other. Currently, there are 11 analysts who rate Zayo Group Holdings a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ZAYO - FREE

TheStreet Quant Ratings rates Zayo Group Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, generally high debt management risk and generally disappointing historical performance in the stock itself. Get the full Zayo Group Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

China Biologic Products (CBPO) - FREE Research Report

Liu Zhijing CBPO, who is Corporate Vice President at China Biologic Products, sold 282 shares at $108.00 on March 15, 2016. Following this transaction, the Corporate Vice President owned 718 shares meaning that the stake was reduced by 28.2% with the 282-share transaction.

The shares most recently traded at $110.44, up $2.44, or 2.21% since the insider transaction. Historical insider transactions for China Biologic Products go as follows:

  • 4-Week # shares sold: 4.3 million
  • 12-Week # shares sold: 4.3 million
  • 24-Week # shares sold: 4.5 million

The average volume for China Biologic Products has been 293,100 shares per day over the past 30 days. China Biologic Products has a market cap of $3.0 billion and is part of the health care sector and drugs industry. Shares are down 22.88% year-to-date as of the close of trading on Tuesday.

China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. The company has a P/E ratio of 34.2. Currently, there are 3 analysts who rate China Biologic Products a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CBPO - FREE

TheStreet Quant Ratings rates China Biologic Products as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full China Biologic Products Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.